FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161504245> ?p ?o ?g. }

• W2161504245 endingPage "592" @default.
• W2161504245 startingPage "584" @default.
• W2161504245 abstract "Everolimus is an immunosuppressive agent that reduces cardiac allograft vasculopathy. This report presents the 24-month results of a multicenter trial of everolimus vs azathioprine in heart transplantation.A total of 634 patients were randomized to receive 1.5 mg everolimus, 3 mg everolimus or azathioprine, with cyclosporine and steroids. A 12-month, double-blind, double-dummy period was followed by a 12-month open-label period.At 24 months, the percentage of patients reaching the composite efficacy end-points was significantly lower with everolimus (1.5 mg: 45.9%, p = 0.016; 3 mg: 36.0%, p < 0.001) than with azathioprine (57.5%). The change in maximal intimal thickness from baseline to 24 months was significantly smaller with everolimus 1.5 mg (0.07 mm, p = 0.014) and 3 mg (0.06 mm, p = 0.004) compared with azathioprine (0.15 mm). The 24-month incidence of vasculopathy was 33.3% with everolimus 1.5 mg, 45.5% with everolimus 3 mg and 58.3% with azathioprine (p = 0.017 vs everolimus 1.5 mg). Incidence of cytomegalovirus infection was 3-fold lower in patients receiving everolimus compared with azathioprine (7.2% and 7.1% in the 1.5-mg and 3-mg everolimus cohorts, respectively, and 21% in the azathioprine group; p < 0.0001). Median serum creatinine levels at 24 months were higher with everolimus than with azathioprine, but decreased when cyclosporine exposure was reduced (everolimus 1.5 mg: baseline 167 micromol, after 6 months 157.5 micromol; everolimus 3 mg: baseline 185.6 micromol, after 6 months 160 micromol; azathioprine: baseline 123.3 micromol, after 6 months 127 micromol).Everolimus significantly reduced acute rejection and limited the progression of allograft vasculopathy at 24 months compared with azathioprine. Although graft and patient survival was comparable at 24 months, everolimus therapy may improve longer-term outcomes after heart transplantation." @default.
• W2161504245 created "2016-06-24" @default.
• W2161504245 creator A5010476289 @default.
• W2161504245 creator A5037604816 @default.
• W2161504245 creator A5039589228 @default.
• W2161504245 creator A5041840008 @default.
• W2161504245 creator A5042536098 @default.
• W2161504245 creator A5049911248 @default.
• W2161504245 creator A5054954264 @default.
• W2161504245 creator A5055658877 @default.
• W2161504245 creator A5057854457 @default.
• W2161504245 creator A5062013889 @default.
• W2161504245 creator A5065481567 @default.
• W2161504245 creator A5067239184 @default.
• W2161504245 creator A5076902671 @default.
• W2161504245 creator A5077504226 @default.
• W2161504245 creator A5080613283 @default.
• W2161504245 date "2007-06-01" @default.
• W2161504245 modified "2023-10-17" @default.
• W2161504245 title "Prevention of Acute Rejection and Allograft Vasculopathy by Everolimus in Cardiac Transplants Recipients: A 24-Month Analysis" @default.
• W2161504245 cites W111178072 @default.
• W2161504245 cites W1502313580 @default.
• W2161504245 cites W1967535124 @default.
• W2161504245 cites W1992128480 @default.
• W2161504245 cites W2008800889 @default.
• W2161504245 cites W2015638436 @default.
• W2161504245 cites W2019967722 @default.
• W2161504245 cites W2028549543 @default.
• W2161504245 cites W2031722838 @default.
• W2161504245 cites W2035881418 @default.
• W2161504245 cites W2044866260 @default.
• W2161504245 cites W2046056542 @default.
• W2161504245 cites W2047698259 @default.
• W2161504245 cites W2050859884 @default.
• W2161504245 cites W2054784910 @default.
• W2161504245 cites W2061318236 @default.
• W2161504245 cites W2084108198 @default.
• W2161504245 cites W2089062413 @default.
• W2161504245 cites W2107218339 @default.
• W2161504245 cites W2113344918 @default.
• W2161504245 cites W2115012618 @default.
• W2161504245 cites W2115225372 @default.
• W2161504245 cites W2115655550 @default.
• W2161504245 cites W2122783053 @default.
• W2161504245 cites W2154971806 @default.
• W2161504245 cites W2322594535 @default.
• W2161504245 cites W3041047318 @default.
• W2161504245 doi "https://doi.org/10.1016/j.healun.2007.03.005" @default.
• W2161504245 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17543781" @default.
• W2161504245 hasPublicationYear "2007" @default.
• W2161504245 type Work @default.
• W2161504245 sameAs 2161504245 @default.
• W2161504245 citedByCount "103" @default.
• W2161504245 countsByYear W21615042452012 @default.
• W2161504245 countsByYear W21615042452013 @default.
• W2161504245 countsByYear W21615042452014 @default.
• W2161504245 countsByYear W21615042452015 @default.
• W2161504245 countsByYear W21615042452016 @default.
• W2161504245 countsByYear W21615042452017 @default.
• W2161504245 countsByYear W21615042452018 @default.
• W2161504245 countsByYear W21615042452019 @default.
• W2161504245 countsByYear W21615042452020 @default.
• W2161504245 countsByYear W21615042452021 @default.
• W2161504245 countsByYear W21615042452022 @default.
• W2161504245 countsByYear W21615042452023 @default.
• W2161504245 crossrefType "journal-article" @default.
• W2161504245 hasAuthorship W2161504245A5010476289 @default.
• W2161504245 hasAuthorship W2161504245A5037604816 @default.
• W2161504245 hasAuthorship W2161504245A5039589228 @default.
• W2161504245 hasAuthorship W2161504245A5041840008 @default.
• W2161504245 hasAuthorship W2161504245A5042536098 @default.
• W2161504245 hasAuthorship W2161504245A5049911248 @default.
• W2161504245 hasAuthorship W2161504245A5054954264 @default.
• W2161504245 hasAuthorship W2161504245A5055658877 @default.
• W2161504245 hasAuthorship W2161504245A5057854457 @default.
• W2161504245 hasAuthorship W2161504245A5062013889 @default.
• W2161504245 hasAuthorship W2161504245A5065481567 @default.
• W2161504245 hasAuthorship W2161504245A5067239184 @default.
• W2161504245 hasAuthorship W2161504245A5076902671 @default.
• W2161504245 hasAuthorship W2161504245A5077504226 @default.
• W2161504245 hasAuthorship W2161504245A5080613283 @default.
• W2161504245 hasConcept C126322002 @default.
• W2161504245 hasConcept C126894567 @default.
• W2161504245 hasConcept C141071460 @default.
• W2161504245 hasConcept C2776760755 @default.
• W2161504245 hasConcept C2777921159 @default.
• W2161504245 hasConcept C2778849806 @default.
• W2161504245 hasConcept C2779134260 @default.
• W2161504245 hasConcept C2779699572 @default.
• W2161504245 hasConcept C2911091166 @default.
• W2161504245 hasConcept C71924100 @default.
• W2161504245 hasConcept C90924648 @default.
• W2161504245 hasConcept C98274493 @default.
• W2161504245 hasConceptScore W2161504245C126322002 @default.
• W2161504245 hasConceptScore W2161504245C126894567 @default.
• W2161504245 hasConceptScore W2161504245C141071460 @default.
• W2161504245 hasConceptScore W2161504245C2776760755 @default.
• W2161504245 hasConceptScore W2161504245C2777921159 @default.

• next